Carlos Augusto de Andrade

Learn More
PURPOSE The aim of this study was to assess the impact of sunitinib treatment in a non-screened group of patients with metastatic renal cell cancer (mRCC) treated by the Brazilian Unified Health System (SUS) at a single reference institution. MATERIAL AND METHODS Retrospective cohort study, which evaluated patients with mRCC who received sunitinib between(More)
  • 1